Yayıncı "Colegio de Farmaceuticos de la Provincia de Buenos Aires" Eczacılık Fakültesi için listeleme
Toplam kayıt 10, listelenen: 1-10
-
Design and characterization of montelukast sodium loaded kollidon® SR nanoparticles and evaluation of release kinetics and cytotoxicity potential
(Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2019)The objective of this research was to design and characterize montelukast sodium (MS) loaded novel nanosized and biocompatible Kollidon® SR nanoparticles to provide prolonged release behavior that can improve bioavailability, ... -
Dexketoprofen trometamol-loaded kollidon® SR and eudragit® RS 100 polymeric nanoparticles: Formulation and in vitro-in vivo evaluation
(Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2017)Development and in vivo/in vitro evaluation of dexketoprofen trometamol (DT)-loaded nanosized, controlled release drug delivery system was aimed in this study.. DT-loaded Kollidon® SR (KSR) and Eudragit® RS 100 (ERS) ... -
Effects of different derivatives of eudragit polymer on entrapment efficiency, in vitro dissolution, release kinetics and cell viability results on extended release flurbiprofen loaded nanomedicines
(Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2018)The purpose of the present investigation was to design and compare the release characteristics of sustained-release formulations of Flurbiprofen (FLB) loaded nanoparticles (NPs) by using spray-dryer technique using Eudragit ... -
Formulation and in vitro evaluation of moxifloxacin hydrochloride-loaded polymeric nanoparticles for ocular application
(Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2018)The primary purpose of this study was to extend the time of interaction of the carrier with the negatively charged ocular surface for enhanced penetration in order to improve ocular bioavailability. Moxifloxacin hydrochloride ... -
New approach to hypertension treatment: Carvediol-loaded PLGA nanoparticles, preparation, in vitro characterization and gastrointestinal stability
(Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2018)Carvedilol (CVL) has advantages over the first generation of ß-blockers in patients with heart failure due to its properties of reducing cardiovascular morbidity and mortality. On the other hand, CVL has a short half-life ... -
Ornidazole incorporated chitosan nanoparticles for ocular application
(Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2015)Considering the low ocular bioavailability of conventional formulations used for ocular bacterial infection treatment, there is a need for developing efficient modern drug delivery systems. Main attempt in this study was ... -
Preparation and in vitro evaluation of DNA-bonded polymeric nanoparticles as new approach for transcutaneous vaccination
(Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2017)The objective of this study was to develop a DNA vaccine, which can be applied topically as a cream containing plasmid DNA (pDNA)/cationic polymeric nanoparticle (PP) complex. The selected pDNA was pCMV-S encoding hepatitis ... -
Preparation, characterization and in vitro evaluation of dirithromycin loaded Eudragitr® RS100 nanoparticles for topical application
(Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2017)The purpose of the study was to formulate dirithromycin (DR) loaded Eudragit® RS 100 (ERS) nanoparticles for topical application and to analyze the physical and chemical characteristics and in vitro toxicity of the prepared ... -
Studies on rosuvastatin calcium incorporated chitosan salt nanoparticles
(Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2016)Cardiovascular diseases are the leading causes of death worldwide and rosuvastatin calcium (RCa) is one of the most effective drugs used for the prevention of coronary heart diseases. Considering low aqueous solubility ... -
Voriconazole incorporated polymeric nanoparticles for ocular application
(Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2017)Limitations of topical ocular application lead to unsufficient treatment in severe ocular disorders, therefore the researchers focused on novel drug delivery systems for the achievement of enhanced ocular bioavailability. ...